# IO Biotech (stock symbol: IOBT) Logo in transparent PNG and SVG formats

## IO Biotech Logo large

### IO Biotech Logo large Download PNG (56.91 KB)

![IO Biotech Logo large Download PNG (56.91 KB)](/img/orig/IOBT_BIG-a59d63da.png)

### IO Biotech Logo large Download SVG (7.11 KB)

![IO Biotech Logo large Download SVG (7.11 KB)](/img/orig/IOBT_BIG-0879bb81.svg)

## IO Biotech Logo icon format

### IO Biotech Logo icon format Download PNG (57.64 KB)

![IO Biotech Logo icon format Download PNG (57.64 KB)](/img/orig/IOBT-583dfee2.png)

### IO Biotech Logo icon format Download SVG (1.17 KB)

![IO Biotech Logo icon format Download SVG (1.17 KB)](/img/orig/IOBT-239a95d0.svg)

## IO Biotech Logo large for dark backgrounds

### IO Biotech Logo large for dark backgrounds Download PNG (34.61 KB)

![IO Biotech Logo large for dark backgrounds Download PNG (34.61 KB)](/img/orig/IOBT_BIG.D-225bae42.png)

### IO Biotech Logo large for dark backgrounds Download SVG (6.75 KB)

![IO Biotech Logo large for dark backgrounds Download SVG (6.75 KB)](/img/orig/IOBT_BIG.D-c53f4928.svg)

## IO Biotech Logo icon format for dark backgrounds

### IO Biotech Logo icon format for dark backgrounds Download PNG (35.43 KB)

![IO Biotech Logo icon format for dark backgrounds Download PNG (35.43 KB)](/img/orig/IOBT.D-9375f4d9.png)

### IO Biotech Logo icon format for dark backgrounds Download SVG (1.14 KB)

![IO Biotech Logo icon format for dark backgrounds Download SVG (1.14 KB)](/img/orig/IOBT.D-459ce20f.svg)

## About IO Biotech

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

1. Website domain: iobiotech.com
2. Employees: 32
3. Marketcap: $55.03 Million USD


## Categories
- [x] ðŸ‡©ðŸ‡° Denmark
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
